Efficient and selective tumor cell lysis and induction of apoptosis in melanoma cells by a conditional replication-competent CD95L adenovirus.

The high mortality of melanoma demands the development of new strategies, and gene therapy may be considered provided improvements in efficacy and selectivity. Overexpression of the death ligand CD95L/FasL has been shown in previous studies as highly effective for apoptosis induction in melanoma cells. For efficient and selective targeting of melanoma, a conditional replication-competent adenoviral vector was constructed (Ad5-FFE-02), which drives CD95L expression by a tetracycline-inducible promoter. For restricting its replication to melanoma cells, the adenoviral E1A gene is controlled by a tyrosinase-derived promoter. Furthermore, adenoviral E1B was deleted and a mutated E1A was used to preferentially support replication in tumor cells. Proving its high selectivity and efficiency, strong expression of E1A and doxycycline-dependent induction of CD95L were characteristic for tyrosinase-positive melanoma cells after Ad5-FFE-02 transduction, whereas absent in non-melanoma cell lines. Importantly, Ad5-FFE-02-mediated cell lysis was restricted to melanoma cells, and induction of apoptosis was found only in tyrosinase and CD95 expressing cells. Finally, the combination of adenoviral replication and CD95L-mediated apoptosis resulted in an enhanced repression of melanoma cell growth. This new adenoviral vector may provide a basis for an efficient targeting of melanoma.
AuthorsLothar F Fecker, Magdalena Schmude, Stefanie Jost, Amir M Hossini, Almudena Hurtado Picó, Xiaomin Wang, Constanze Schwarz, Henry Fechner, Jürgen Eberle
JournalExperimental dermatology (Exp Dermatol) Vol. 19 Issue 8 Pg. e56-66 (Aug 2010) ISSN: 1600-0625 [Electronic] Denmark
PMID19725869 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenovirus E1A Proteins
  • Fas Ligand Protein
  • Doxycycline
  • Adenoviridae (genetics, physiology)
  • Adenovirus E1A Proteins (metabolism)
  • Apoptosis
  • Cell Line, Tumor
  • Doxycycline (pharmacology)
  • Fas Ligand Protein (genetics, metabolism)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Gene Expression Regulation, Viral (drug effects)
  • Genetic Therapy
  • Genetic Vectors
  • Humans
  • Melanoma (metabolism, pathology, therapy)
  • Plasmids
  • Skin Neoplasms (metabolism, pathology, therapy)
  • Virus Replication (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: